The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999-2018.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2003-

Prediabetic State*/blood ; Prediabetic State*/mortality ; Cardiovascular Diseases*/mortality ; Cardiovascular Diseases*/blood ; Nutrition Surveys* ; Diabetes Mellitus*/mortality ; Diabetes Mellitus*/blood; Humans ; Male ; Female ; Middle Aged ; Adult ; United States/epidemiology ; Cholesterol, HDL/blood ; Aged ; Proportional Hazards Models ; Cause of Death

Background: The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) serves as a novel composite lipid indicator for atherosclerosis. However, the association between NHHR and mortality in patients with diabetes or prediabetes remains unclear. Consequently, the objective of this study was to investigate the relationship between NHHR and both all-cause and cardiovascular mortality in US adults with diabetes or prediabetes.
Methods: This study included 12,578 adult participants with diabetes or prediabetes from the US National Health and Nutrition Examination Survey (1999-2018). Mortality outcomes were ascertained by linking to the National Death Index (NDI) record up to December 31, 2019. We employed a weighted multivariate Cox proportional hazards model and restricted cubic splines to assess the associations between NHHR and all-cause and cardiovascular mortality. A segmented Cox proportional hazards model was used for evaluating threshold effects. Furthermore, a competing risks analysis was performed to explore the relationship between NHHR and cardiovascular mortality.
Results: During a median follow-up period of 8.08 years, 2403 participants encountered all-cause mortality, with 662 of them specifically succumbing to cardiovascular mortality. The restricted cubic splines revealed a U-shaped association between NHHR and all-cause mortality, while an L-shaped association was observed for cardiovascular mortality. The analysis of threshold effects revealed that the inflection points for NHHR and all-cause and cardiovascular mortality were 2.72 and 2.83, respectively. Specifically, when the baseline NHHR was below the inflection points, a negative correlation was observed between NHHR and both all-cause mortality (HR: 0.76, 95% CI: 0.68-0.85) and cardiovascular mortality (HR: 0.70, 95% CI: 0.57-0.85). Conversely, when the baseline NHHR exceeded the inflection points, a positive correlation was observed between NHHR and both all-cause mortality (HR: 1.11, 95% CI: 1.06-1.16) and cardiovascular mortality (HR: 1.08, 95% CI: 1.00-1.16).
Conclusions: Among US adults with diabetes or prediabetes, a U-shaped association was observed between NHHR and all-cause mortality, whereas an L-shaped association was identified with cardiovascular mortality. The inflection points for all-cause and cardiovascular mortality were 2.72 and 2.83, respectively.
(© 2024. The Author(s).)

Diabetes Metab Syndr Obes. 2022 May 31;15:1677-1686. (PMID: 35669362)
Eur Heart J. 2017 Aug 21;38(32):2478-2486. (PMID: 28419274)
Circulation. 2016 Jun 14;133(24):2459-502. (PMID: 27297342)
Diabetologia. 2021 Sep;64(9):1917-1926. (PMID: 34255113)
Int J Cardiol. 2017 Jan 15;227:950-955. (PMID: 27939140)
Lancet. 2023 Jul 15;402(10397):203-234. (PMID: 37356446)
Diabetes. 2020 Oct;69(10):2061-2063. (PMID: 32958608)
Lipids Health Dis. 2024 Jan 13;23(1):17. (PMID: 38218917)
Lipids Health Dis. 2015 Apr 09;14:24. (PMID: 25885111)
Front Cardiovasc Med. 2022 Jul 07;9:903481. (PMID: 35872887)
BMJ. 2020 Dec 8;371:m4266. (PMID: 33293274)
Sci Rep. 2020 Jul 29;10(1):12749. (PMID: 32728174)
Circ Res. 2014 Jan 3;114(1):205-13. (PMID: 24385513)
Scand J Prim Health Care. 2010 Jun;28(2):121-7. (PMID: 20470020)
JAMA. 2012 Jun 20;307(23):2499-506. (PMID: 22797450)
JAMA. 2009 Nov 11;302(18):1993-2000. (PMID: 19903920)
Lancet. 2023 Jun 3;401(10391):1849. (PMID: 37270233)
Front Cardiovasc Med. 2021 Jul 14;8:707701. (PMID: 34336961)
Nat Rev Endocrinol. 2018 Feb;14(2):88-98. (PMID: 29219149)
Circulation. 2016 Feb 9;133(6):601-9. (PMID: 26858290)
BMJ. 2022 Mar 24;376:e067731. (PMID: 35331984)
Lipids Health Dis. 2023 Nov 6;22(1):187. (PMID: 37932803)
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33. (PMID: 33298413)
Int J Cardiol. 2013 Oct 3;168(3):2678-83. (PMID: 23545148)
JAMA Intern Med. 2022 Aug 1;182(8):883-886. (PMID: 35788262)
Atherosclerosis. 2023 Oct;383:117312. (PMID: 37826864)
Lancet. 2023 Apr 15;401(10384):1302-1312. (PMID: 36931289)
Circulation. 2022 Mar;145(9):e722-e759. (PMID: 35000404)
Biomark Med. 2023 Jan;17(1):29-39. (PMID: 36994674)
Biomed Res Int. 2020 Mar 07;2020:7146028. (PMID: 32219140)
Vital Health Stat 2. 2020 Apr;(184):1-35. (PMID: 33663649)
Prog Cardiovasc Dis. 2019 Jul - Aug;62(4):334-341. (PMID: 31442512)
J Am Coll Cardiol. 2019 Jul 9;74(1):70-79. (PMID: 31272554)
Biomolecules. 2023 Jan 04;13(1):. (PMID: 36671490)
Circulation. 1992 Sep;86(3):1046-60. (PMID: 1355411)
Lipids Health Dis. 2024 Apr 13;23(1):102. (PMID: 38615008)
Diabetes Res Clin Pract. 2022 Jan;183:109119. (PMID: 34879977)
Cardiovasc Diabetol. 2018 Aug 31;17(1):122. (PMID: 30170598)
J Affect Disord. 2024 Jan 1;344:451-457. (PMID: 37838268)
Circ Res. 2019 May 10;124(10):1505-1518. (PMID: 31071007)
Rev Esp Cardiol (Engl Ed). 2022 May;75(5):429. (PMID: 35525570)
Lancet. 2020 Oct 17;396(10258):1204-1222. (PMID: 33069326)
Int J Mol Sci. 2020 Mar 06;21(5):. (PMID: 32155866)

Keywords: Cardiovascular disease; Diabetes; Mortality; NHANES; NHHR; Prediabetes

0 (Cholesterol, HDL)

Date Created: 20240807 Date Completed: 20240808 Latest Revision: 20240810

20240812

PMC11304565

10.1186/s12916-024-03536-3

39113030